Stifel Financial Corp Oncolytics Biotech Inc Transaction History

Stifel Financial Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$0.98 - $1.51 $3,178 - $4,896	3,243 Added 25.61%	15,905 $20,000
Q2 2022 Aug 15, 2022	BUY	$0.85 - $1.59 $10,762 - $20,132	12,662 New	12,662 $13,000

1.38M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $44.6M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.